SynVaccine Company
SynVaccine develops preventive viral vaccines for various major human pathogens.
Technology:
Biologics (vaccine)
Industry:
Geroscience
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2013-01-01
Employees Number:
1-10
Investors Number:
2
Total Funding:
1756064
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-09-23
Last Funding Type:
Seed
Register and Claim Ownership